Literature DB >> 8084995

Successful treatment of interferon alfa-induced mood disorder with nortriptyline.

L S Goldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8084995     DOI： 10.1016/S0033-3182(94)71769-2

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  4 in total

1.  Major depressive disorder in hepatitis C: an open-label trial of escitalopram.

Authors:  Ondria C Gleason; William R Yates; Michelle A Philipsen
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 2.  Neurobehavioral effects of interferon therapy.

Authors:  Alan D Valentine; Christina A Meyers
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

3.  Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.

Authors:  Ondria C Gleason; John C Fucci; William R Yates; Michelle A Philipsen
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

4.  Major depression during interferon-alpha treatment: vulnerability and prevention.

Authors:  Francis E Lotrich
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.